This ETF offers 3x daily leveraged exposure to an index consisting of healthcare stocks, including companies engaged in the manufacture of health care products and materials, and those responsible for providing health-related services. Given the narrow focus and the leveraged exposure, CURE doesn't belong in any long-term, buy-and-hold portfolios; this ETF is designed for risk-tolerant investors looking to express a bullish outlook on a specific sector of the U.S. economy over a relatively short period of time. Investors looking to establish a non-leveraged tilt towards health care stocks have a number of choices in the Health & Biotech Equities ETFdb Category, including XLV (which is linked to the same index as this product). Investors considering this leveraged ETF should understand the impact that the daily reset feature has on the risk/return profile. CURE is designed to offer 3x leveraged exposure over the course of a single trading session only; those holding this fund for longer or shorter than this time period may experience returns that vary (sometimes significantly) from the target multiple. CURE can still be used effectively as part of longer-term strategies; investors must simply understand the nuances of compounding returns in a daily reset fund, and be willing/able to monitor and rebalance as needed. Investors looking to make a leveraged bet against health care stocks have SICK available, while those seeking 2x exposure may prefer RXL (long) or RXD (short).
The adjacent table gives investors an individual Realtime Rating for CURE on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Leveraged Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.View the Category Report
The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb.com Category.
This ETF is not currently available for commission free trading on any platforms.
There are 11 other ETFs in the Leveraged Equities ETFdb.com Category that are also eligible for commission free trading:
CURE does not have an ESG score. There are no ESG themes that map to this ETF.
This section shows how this ETF has performed relative to its peer group ETFdb.com Category.
This section compares the fund flows of this ETF to peers in the same ETFdb.com Category.
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of CURE relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.